#news #biotech Realm scraps eye drug after midphase flop, sinking stock

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Realm scraps eye drug after midphase flop, sinking stock .Realm Therapeutics has scrapped development of PR013 after the opthalmic drops failed to improve outcomes in patients with allergic conjunctivitis. The setback wiped almost 30% off Realm’s stock as investors digested the loss of the program and assessed its implications for the rest of the pipeline.

from FierceBiotech: Biotech http://ift.tt/2p8H1ps